NXN-188 is a novel dual-action small molecule compound that combines inhibition of neuronal nitric oxide synthase (nNOS) with 5-HT receptor agonism and is currently in development for the treatment of acute migraine.
Molekulargewicht:
484.59
CAS Nummer:
[6634-56-6]
Formel:
C27H36N2O6
T202429
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten